🔎 Trials Near Me

Home › Stomach Cancer › Massachusetts › Boston

Stomach Cancer clinical trials in Boston, MA

32 studies for Stomach Cancer are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Distance-Based Exercise to Preserve Function and Prevent Disability

Recruiting
  • Dana-Farber Cancer Institute, Boston
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT07059884

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

RecruitingPhase 1
  • Dana Farber Cancer Institute, Boston
Ages 19 and older · All sexes · Updated Oct 1, 2026 · NCT06586957

A Phase 1 Study of IM-1617 in Participants With Advanced Cancer

RecruitingPhase 1
  • Massachusetts General Hospital, Boston
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07578571

IKS014 in Advanced Solid Tumors That Express HER2

RecruitingPhase 1
  • Dana Farber Cancer Institute, Boston
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT05872295

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

RecruitingPhase 1/2
  • Tufts Medical Center, Boston
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06047379

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

RecruitingPhase 1/2
  • Dana Farber Cancer Institute, Boston
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06128551

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

RecruitingPhase 1
  • Massachusetts General Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07114601

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

RecruitingPhase 1
  • Massachusetts General Hospital, Boston
  • Beth Israel Deaconess Medical Center, Boston
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07213791

Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.

RecruitingPhase 3
  • Massachusetts General Hospital, Boston
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07217704

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

RecruitingPhase 1
  • Dana Farber Cancer Institute, Boston
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT06293898

Resilience and Equity in Aging, Cancer, and Health (REACH)

Recruiting
  • Dana-Farber Cancer Institute, Boston
Ages 65 and older · All sexes · Updated Sep 10, 2026 · NCT04674267

A Phase 1/1b Study of IAM1363 in HER2 Cancers

RecruitingPhase 1
  • Massachusetts General Hospital, Boston
  • Dana Farber Cancer Institute, Boston
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06253871

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

RecruitingPhase 1/2
  • Dana Farber Cancer Institute, Boston
  • Massachusetts General Hospital, Boston
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT07070232

Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA

RecruitingPhase 2
  • Massachusetts General Hospital, Boston
Ages 18 and older · All sexes · Updated Aug 28, 2026 · NCT07070466

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

RecruitingPhase 1
  • Mass General Cancer Center, Boston
Ages 18 and older · All sexes · Updated Aug 27, 2026 · NCT07227168

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

RecruitingPhase 1/2
  • Massachusetts General Hospital Cancer Center, Boston
Ages 18 and older · All sexes · Updated Aug 11, 2026 · NCT05592626

Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

RecruitingPhase 3
  • Tufts Medical Center, Boston
Ages 18 and older · All sexes · Updated Aug 10, 2026 · NCT06731478

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

RecruitingPhase 1/2
  • Massachusetts General Hospital - Dana Farber, Boston
Ages 18 and older · All sexes · Updated Jul 29, 2026 · NCT03526835

A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

RecruitingPhase 1
  • Beth Israel Deaconess Medical Center, Boston
Ages 18 and older · All sexes · Updated Jul 22, 2026 · NCT06131840

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

RecruitingPhase 1
  • Massachusetts General Hospital, Boston
  • Brigham & Women's Hospital, Boston
  • Beth Israel Deaconess Medical Center,East Campus Research Pharmacy, Boston
  • and 2 more
Ages 18 and older · All sexes · Updated Jul 6, 2026 · NCT04389632

Clonal Hematopoiesis Chemotherapy and Radiation Effects Study

RecruitingObservational study
  • Dana-Farber Cancer Institute, Boston
Ages 18 and older · All sexes · Updated Jun 30, 2026 · NCT07675967

Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)

RecruitingPhase 2
  • I-Mab Site 1002, Boston
Ages 18 and older · All sexes · Updated May 14, 2026 · NCT07432295

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

RecruitingPhase 1/2
  • Massachusetts General Hospital, Boston
Ages 18 and older · All sexes · Updated May 6, 2026 · NCT06239194

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

RecruitingPhase 1/2
  • Massachusetts General Hospital, Boston
Ages 18 and older · All sexes · Updated Mar 27, 2026 · NCT06395519

Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors

RecruitingPhase 1
  • Mass General Hospital, Boston
Ages 18 and older · All sexes · Updated Mar 5, 2026 · NCT04900818

CONFIRM: Magnetic Resonance Guided Radiation Therapy

Recruiting
  • Brigham & Women's Hospital, Boston
  • Dana Farber Cancer Institute, Boston
Ages 18 and older · All sexes · Updated Feb 9, 2026 · NCT04368702

Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers

RecruitingPhase 1/2
  • Massachusetts General Hospital, Boston
Ages 18 and older · All sexes · Updated Jan 16, 2026 · NCT02584244

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

RecruitingPhase 1/2
  • Dana Farber Cancer Institute, Boston
Ages 18 and older · All sexes · Updated Sep 24, 2025 · NCT05941507

Comprehensive Outcomes for After Cancer Health

RecruitingHealthy volunteers welcome
  • Dana Farber Cancer Institute, Boston
Ages 18 and older · All sexes · Updated Dec 11, 2024 · NCT05349227

About Stomach Cancer

Did you know risk factors for stomach (gastric) cancer include a diet high in salty or smoked food or having an H. pylori infection? Learn more here.

More about Stomach Cancer on MedlinePlus

Stomach Cancer trials in other cities

Other studies in Boston

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.